Single Agent JNJ-56022473 in MDS and AML Patients FAILING HYPOMETHYLATING AGENT BASED THERAPY

Clinical trial NCT02992860 · TERMINATED

Trial details

NCT number: NCT02992860
Sponsor: GWT-TUD GmbH
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)Acute Myeloid Leukemia (AML)

Start date: 2016-07-01
Primary completion: 2018-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.